Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients
暂无分享,去创建一个
B. Clotet | J. Mallolas | J. Macías | J. Pineda | S. Moreno | L. López-Cortés | P. Domingo | H. Knobel | E. Ortega | J. Carton | J. Iribarren | K. Neukam | M. Jiménez-Expósito | I. de los Santos | Manell Crespo